Bart Health NHS Trust- Royal London Hospital

London E1 1BB

0 studies enrolling now · 1 studies all time

What they study most

Nonalcoholic Steatohepatitis (NASH) With Fibrosis

Studies at this site

• Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH) — Stopped early